Abstract
The short-term therapeutic impacts of stem cells and their derivatives were frequently reported in preclinical investigations of ischemic stroke (IS); however, several drawbacks including accessibility, abundancy, and ethical concerns limited their clinical application. We describe here for the first time the therapeutic potential of human hair follicle-derived stem cells (hHFSCs) and their conditioned medium (CM) in a rat model of IS. Furthermore, we hypothesized that a combination of cell therapy with repeated CM administration might enhance the restorative efficiency of this approach compared to each treatment alone. Middle cerebral artery occlusion was performed for 30 min to induce IS. Immediately after reperfusion, hHFSCs were transplanted through the intra-arterial route and/or hHFSC-CM administered intranasally. The neurological outcomes, short-term spatial working memory, and infarct size were evaluated. Furthermore, relative expression of seven target genes in three categories of neuronal markers, synaptic markers, and angiogenic markers was assessed. The hHFSCs and hHFSC-CM treatments improved neurological impairments and reduced infarct size in the IS rats. Moreover, molecular data elucidated that IS was accompanied by attenuation in the expression of neuronal and synaptic markers in the evaluated brain regions and the interventions rescued these expression changes. Although there was no considerable difference between hHFSCs and hHFSC-CM treatments in the improvement of neurological function and decrement of infarct size, combination therapy was more effective to reduce infarction and elevation of target gene expression especially in the hippocampus. These findings highlight the curative potential of hHFSCs and their CM in a rat model of IS.
Graphical Abstract
Similar content being viewed by others
Data Availability
The datasets used and/or analyzed during the current study are available from the corresponding authors on reasonable request.
References
Collaborators GBDS (2021) Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 20(10):795–820. https://doi.org/10.1016/S1474-4422(21)00252-0
Krishnamurthi RV, Ikeda T, Feigin VL (2020) Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage: a systematic analysis of the global burden of disease study 2017. Neuroepidemiology 54(2):171–179. https://doi.org/10.1159/000506396
Li Z, Dong X, Tian M, Liu C, Wang K, Li L et al (2020) Stem cell-based therapies for ischemic stroke: a systematic review and meta-analysis of clinical trials. Stem Cell Res Ther 11(1):252. https://doi.org/10.1186/s13287-020-01762-z
Singh M, Pandey PK, Bhasin A, Padma MV, Mohanty S (2020) Application of stem cells in stroke: a multifactorial approach. Front Neurosci 14:473. https://doi.org/10.3389/fnins.2020.00473
Drago D, Cossetti C, Iraci N, Gaude E, Musco G, Bachi A et al (2013) The stem cell secretome and its role in brain repair. Biochimie 95(12):2271–2285. https://doi.org/10.1016/j.biochi.2013.06.020
Sieber-Blum M (2014) Human epidermal neural crest stem cells as candidates for cell-based therapies, disease modeling, and drug discovery. Birth Defects Res Part C Embryo Today 102(3):221–226. https://doi.org/10.1002/bdrc.21073
Salehi MS, Pandamooz S, Safari A, Jurek B, Tamadon A, Namavar MR et al (2020) Epidermal neural crest stem cell transplantation as a promising therapeutic strategy for ischemic stroke. CNS Neurosci Ther 26(7):670–681. https://doi.org/10.1111/cns.13370
Zhang X, Tang H, Mao S, Li B, Zhou Y, Yue H et al (2020) Transplanted hair follicle stem cells migrate to the penumbra and express neural markers in a rat model of cerebral ischaemia/reperfusion. Stem Cell Res Ther 11(1):413. https://doi.org/10.1186/s13287-020-01927-w
Wang J, Zhang P, Tang Z (2020) Animal models of transient ischemic attack: a review. Acta Neurol Belg 120(2):267–275. https://doi.org/10.1007/s13760-020-01295-5
Li Y, Zhang J (2021) Animal models of stroke. Animal Model Exp Med 4(3):204–219. https://doi.org/10.1002/ame2.12179
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M et al (2020) The ARRIVE guidelines 20: updated guidelines for reporting animal research. PLoS Bio 18(7):e3000410. https://doi.org/10.1371/journal.pbio.3000410
Clewes O, Narytnyk A, Gillinder KR, Loughney AD, Murdoch AP, Sieber-Blum M (2011) Human epidermal neural crest stem cells (hEPI-NCSC)–characterization and directed differentiation into osteocytes and melanocytes. Stem Cell Rev Rep 7(4):799–814. https://doi.org/10.1007/s12015-011-9255-5
Sieber-Blum M, Hu Y (2008) Epidermal neural crest stem cells (EPI-NCSC) and pluripotency. Stem Cell Rev 4(4):256–260. https://doi.org/10.1007/s12015-008-9042-0
Vasyliev RG, Gubar OS, Gordiienko IM, Litvinova LS, Rodnichenko AE, Shupletsova VV et al (2019) Comparative analysis of biological properties of large-scale expanded adult neural crest-derived stem cells isolated from human hair follicle and skin dermis. Stem Cells Int 2019:9640790. https://doi.org/10.1155/2019/9640790
Sieber-Blum M, Grim M, Hu YF, Szeder V (2004) Pluripotent neural crest stem cells in the adult hair follicle. Dev Dyn 231(2):258–269. https://doi.org/10.1002/dvdy.20129
Mehrabani D, Hassanshahi MA, Tamadon A, Zare S, Keshavarz S, Rahmanifar F et al (2015) Adipose tissue-derived mesenchymal stem cells repair germinal cells of seminiferous tubules of busulfan-induced azoospermic rats. J Hum Reprod Sci 8(2):103–110. https://doi.org/10.4103/0974-1208.158618
Inoue T, Sugiyama M, Hattori H, Wakita H, Wakabayashi T, Ueda M (2013) Stem cells from human exfoliated deciduous tooth-derived conditioned medium enhance recovery of focal cerebral ischemia in rats. Tissue Eng Part A 19(1–2):24–29. https://doi.org/10.1089/ten.TEA.2011.0385
Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20(1):84–91. https://doi.org/10.1161/01.str.20.1.84
Popp A, Jaenisch N, Witte OW, Frahm C (2009) Identification of ischemic regions in a rat model of stroke. PLoS One 4(3):e4764. https://doi.org/10.1371/journal.pone.0004764
Mousavi SM, Akbarpour B, Karimi-Haghighi S, Pandamooz S, Belem-Filho IJA, Masis-Calvo M et al (2022) Therapeutic potential of hair follicle-derived stem cell intranasal transplantation in a rat model of ischemic stroke. BMC Neurosci 23(1):47. https://doi.org/10.1186/s12868-022-00732-w
Mousavi SM, Karimi-Haghighi S, Chavoshinezhad S, Pandamooz S, Belem-Filho IJA, Keshavarz S et al (2022) The impacts of anesthetic regimens on the middle cerebral artery occlusion outcomes in male rats. NeuroReport 33(13):561–568. https://doi.org/10.1097/WNR.0000000000001816
Ishizaka S, Horie N, Satoh K, Fukuda Y, Nishida N, Nagata I (2013) Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke 44(3):720–726. https://doi.org/10.1161/STROKEAHA.112.677328
Kawabori M, Kuroda S, Ito M, Shichinohe H, Houkin K, Kuge Y et al (2013) Timing and cell dose determine therapeutic effects of bone marrow stromal cell transplantation in rat model of cerebral infarct. Neuropathology 33(2):140–148. https://doi.org/10.1111/j.1440-1789.2012.01335.x
Zhao Q, Hu J, Xiang J, Gu Y, Jin P, Hua F et al (2015) Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke. Brain Res 1624:489–496. https://doi.org/10.1016/j.brainres.2015.08.003
Kraeuter AK, Guest PC, Sarnyai Z (2019) The Y-maze for assessment of spatial working and reference memory in mice. Methods Mol Biol 1916:105–111. https://doi.org/10.1007/978-1-4939-8994-2_10
Chavoshinezhad S, MohseniKouchesfahani H, Ahmadiani A, Dargahi L (2019) Interferon beta ameliorates cognitive dysfunction in a rat model of Alzheimer’s disease: modulation of hippocampal neurogenesis and apoptosis as underlying mechanism. Prog Neuropsychopharmacol Biol Psychiatry 94:109661. https://doi.org/10.1016/j.pnpbp.2019.109661
Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55(4):611–622. https://doi.org/10.1373/clinchem.2008.112797
Gubern C, Hurtado O, Rodríguez R, Morales JR, Romera VG, Moro MA et al (2009) Validation of housekeeping genes for quantitative real-time PCR in in-vivo and in-vitro models of cerebral ischaemia. BMC Mol Biol 10:57. https://doi.org/10.1186/1471-2199-10-57
Kang Y, Wu Z, Cai D, Lu B (2018) Evaluation of reference genes for gene expression studies in mouse and N2a cell ischemic stroke models using quantitative real-time PCR. BMC Neurosci 19(1):3. https://doi.org/10.1186/s12868-018-0403-6
Coelho de Oliveira VC, Silva Dos Santos D, Vairo L, Kasai Brunswick TH, Pimentel LAS, Carvalho AB et al (2017) Hair follicle-derived mesenchymal cells support undifferentiated growth of embryonic stem cells. Exp Ther Med 13(5):1779–1788. https://doi.org/10.3892/etm.2017.4195
Inoue K, Aoi N, Sato T, Yamauchi Y, Suga H, Eto H et al (2009) Differential expression of stem-cell-associated markers in human hair follicle epithelial cells. Lab Invest 89(8):844–856. https://doi.org/10.1038/labinvest.2009.48
Kawabori M, Shichinohe H, Kuroda S, Houkin K (2020) Clinical trials of stem cell therapy for cerebral ischemic stroke. Int J Mol Sci 21(19):7380. https://doi.org/10.3390/ijms21197380
Salehi MS, Safari A, Pandamooz S, Jurek B, Hooshmandi E, Owjfard M et al (2022) The beneficial potential of genetically modified stem cells in the treatment of stroke: a review. Stem Cell Rev Rep 18:412–440. https://doi.org/10.1007/s12015-021-10175-1
Bogatcheva NV, Coleman ME (2019) Conditioned medium of mesenchymal stromal cells: a new class of therapeutics. Biochemistry (Mosc) 84(11):1375–1389. https://doi.org/10.1134/s0006297919110129
Guzman R, Janowski M, Walczak P (2018) Intra-arterial delivery of cell therapies for stroke. Stroke 49(5):1075–1082. https://doi.org/10.1161/strokeaha.117.018288
Salehi MS, Jurek B, Karimi-Haghighi S, Nezhad NJ, Mousavi SM, Hooshmandi E et al (2022) Intranasal application of stem cells and their derivatives as a new hope in the treatment of cerebral hypoxia/ischemia: a review. Rev Neurosci 33(6):583–606. https://doi.org/10.1515/revneuro-2021-0163
Gusel’nikova VV, Korzhevskiy DE (2015) NeuN as a neuronal nuclear antigen and neuron differentiation marker. Acta Naturae 7(2):42–47
Tajiri N, Acosta S, Glover LE, Bickford PC, Jacotte Simancas A, Yasuhara T et al (2012) Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. PLoS One 7(8):e43779. https://doi.org/10.1371/journal.pone.0043779
Hofmeijer J, van Putten MJ (2012) Ischemic cerebral damage: an appraisal of synaptic failure. Stroke 43(2):607–615. https://doi.org/10.1161/strokeaha.111.632943
Chen B, Gao XQ, Yang CX, Tan SK, Sun ZL, Yan NH et al (2009) Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Res 1284:1–11. https://doi.org/10.1016/j.brainres.2009.05.100
Zhang HL, Xie XF, Xiong YQ, Liu SM, Hu GZ, Cao WF et al (2018) Comparisons of the therapeutic effects of three different routes of bone marrow mesenchymal stem cell transplantation in cerebral ischemic rats. Brain Res 1680:143–154. https://doi.org/10.1016/j.brainres.2017.12.017
Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M (2013) Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 33(11):1711–1715. https://doi.org/10.1038/jcbfm.2013.152
Hatakeyama M, Ninomiya I, Kanazawa M (2020) Angiogenesis and neuronal remodeling after ischemic stroke. Neural Regen Res 15(1):16–19. https://doi.org/10.4103/1673-5374.264442
Funding
This study was financially supported by Shiraz University of Medical Sciences (Grant number: 22014) and Iran National Science Foundation (INSF, Grant number: 99008590).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. The study was designed by Sareh Pandamooz, Mohammad Saied Salehi, and Afshin Borhani-Haghighi. Data collection and analysis were performed by Saeideh Karimi-Haghighi, Sadegh Fattahi, Etrat Hooshmandi, Mahnaz Bayat, Maryam Owjfard, Seyedeh Shaghayegh Zafarmand, Mandana Mostaghel, Seyedeh Maryam Mousavi, Nahid Jashire Nezhad, and Vida Eraghi. Material preparation was performed by Anahid Safari, Negar Azarpira, Mehdi Dianatpour, Nima Fadakar, and Abbas Rahimi Jaberi. The manuscript was critically revised by Benjamin Jurek, Carlos Garcia-Esperon, Neil Spratt, and Christopher Levi. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics Approval
Animal procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication, 8th edition, revised 2011). The study was approved by Shiraz University of Medical Sciences, Shiraz, Iran (IR.SUMS.REC.1399.1150). Complying with ARRIVE guidelines[11], all attempts were conducted to decrease animal suffering and minimize the number of animals.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Karimi-Haghighi, S., Pandamooz, S., Jurek, B. et al. From Hair to the Brain: The Short-Term Therapeutic Potential of Human Hair Follicle-Derived Stem Cells and Their Conditioned Medium in a Rat Model of Stroke. Mol Neurobiol 60, 2587–2601 (2023). https://doi.org/10.1007/s12035-023-03223-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-023-03223-z